Issue 17, 2025

Ferrocene conjugated Os(ii) complex for photo-catalytic cancer therapy of triple-negative breast cancer cells

Abstract

A novel ferrocene-conjugated bimetallic Os(II) photocatalyst (OsFe) showed micromolar photocatalytic anticancer activity against triple-negative breast cancer cells via NADH oxidation and caspase 3 activation under visible light.

Graphical abstract: Ferrocene conjugated Os(ii) complex for photo-catalytic cancer therapy of triple-negative breast cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
03 mar 2025
Accepted
03 apr 2025
First published
07 apr 2025

Dalton Trans., 2025,54, 6785-6789

Ferrocene conjugated Os(II) complex for photo-catalytic cancer therapy of triple-negative breast cancer cells

A. Mandal, V. Singh, S. Peters, A. A. Mandal, T. Sadhukhan, B. Koch and S. Banerjee, Dalton Trans., 2025, 54, 6785 DOI: 10.1039/D5DT00515A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements